UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maximal Strength Training Improves Bone Mineral Density and Neuromuscular Performance in Young Adult Women

Journal of strength and conditioning research, 2014-10, Vol.28 (10), p.2935-2945

2014

Volltextzugriff (PDF)

Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?

Bone Reports, 2021-06, Vol.14, p.101095-101095, Article 101095

2021

Volltextzugriff (PDF)

Decreased bone mineral density and reduced bone quality in H+/K+ATPase beta-subunit deficient mice

Journal of cellular biochemistry, 2012-01, Vol.113 (1), p.141-147

2012

Volltextzugriff (PDF)

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

BMC endocrine disorders, 2011-05, Vol.11 (1), p.11-11, Article 11

2011

Volltextzugriff (PDF)

Systemic Leptin Administration in Supraphysiological Doses Maintains Bone Mineral Density and Mechanical Strength Despite Significant Weight Loss

Endocrinology (Philadelphia), 2012-05, Vol.153 (5), p.2245-2253

2012

Volltextzugriff (PDF)

Maximal Strength Training in Postmenopausal Women With Osteoporosis or Osteopenia

Journal of strength and conditioning research, 2013-10, Vol.27 (10), p.2879-2886

2013

Volltextzugriff (PDF)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone

BMC endocrine disorders, 2009-03, Vol.9 (1), p.10-10, Article 10

2009

Volltextzugriff (PDF)

Body composition in adults born preterm with very low birth weight

Pediatric research, 2024-04, Vol.95 (5), p.1316-1324

2024

Volltextzugriff (PDF)

Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells

European journal of oral sciences, 2010-12, Vol.118 (6), p.566-573

2010

Volltextzugriff (PDF)

Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H+/K+ATPase Beta Subunit KO Mice

Journal of cellular biochemistry, 2016-09, Vol.117 (9), p.2089-2096

2016

Volltextzugriff (PDF)

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas

International journal of clinical and experimental pathology, 2011-06, Vol.4 (5), p.444-453

2011

Volltextzugriff (PDF)

Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice

Journal of endocrinology, 2016-08, Vol.230 (2), p.251-262

2016

Volltextzugriff (PDF)

Mo1082 The Effect of Three Months use of Proton Pump Inhibitors on Bone Mineral Density, Bone Markers and Calcium Metabolism in Men With Gastroesophageal Reflux Disease

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-590-S-590

2012

Volltextzugriff (PDF)

Long-term serotonin effects in the rat are prevented by terguride

Regulatory peptides, 2007-10, Vol.143 (1), p.39-46

2007

Volltextzugriff (PDF)

Enamel matrix derivative stimulates expression and secretion of resistin in mesenchymal cells

European journal of oral sciences, 2011-12, Vol.119 (s1), p.366-372

2011

Volltextzugriff (PDF)

495 WITHDRAWN

Gastroenterology (New York, N.Y. 1943), 2009-05, Vol.136 (5), p.A-80-A-80

2009

Volltextzugriff (PDF)

Sa1332 GASTRIC CORPUS MUCOSAL HYPERPLASIA AND NEUROENDOCRINE CELL HYPERPASIA, BUT NOT SPASMOLYTIC POLYPEPTICE-EXPRESSING METAPLASIA, IS PREVENTED BY A GASTRIN-BLOCKER IN H+/K+ ATPASE BETA SUBUNIT DEFICIENT MICE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-319-S-320

2020

Volltextzugriff (PDF)

Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H super(+)/K super(+)ATPase Beta Subunit KO Mice

Journal of cellular biochemistry, 2016-09, Vol.117 (9), p.2089-2096

2016

Volltextzugriff (PDF)

Heavy, Explosive Strength Training For Postmenopausal Women With Osteoporosis: A Pilot Study

Medicine and science in sports and exercise, 2012-05, Vol.44 (5S), p.277-277

2012

Volltextzugriff (PDF)

Different skeletal effects of the peroxisome proliferator activated receptor [alpha] agonist fenofibrate and the PPAR[gamma] agonist pioglitazone

BMC endocrine disorders, 2009-03, Vol.9 (10), p.10

2009

Volltextzugriff (PDF)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone

BMC endocrine disorders, 2009-03, Vol.9, p.10-10

2009

Volltextzugriff (PDF)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)I- agonist fenofibrate and the PPARI3 agonist pioglitazone

BMC endocrine disorders, 2009-01, Vol.9, p.10-10

2009

Volltextzugriff (PDF)

Engineering of Inflammation-Resistant Osteochondral Cells

Gordeladze, Jan O

2013

Volltextzugriff (PDF)

Alterations in the vitamin D endocrine system during pregnancy: A longitudinal study of 855 healthy Norwegian women

PloS one, 2018-04, Vol.13 (4), p.e0195041-e0195041

2018

Volltextzugriff (PDF)

Maternal vitamin D status in pregnancy and molar incisor hypomineralisation and hypomineralised second primary molars in the offspring at 7–9 years of age: a longitudinal study

European archives of paediatric dentistry, 2022-08, Vol.23 (4), p.557-566

2022

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maximal Strength Training Improves Bone Mineral Density and Neuromuscular Performance in Young Adult Women

Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?

Decreased bone mineral density and reduced bone quality in H+/K+ATPase beta-subunit deficient mice

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

Systemic Leptin Administration in Supraphysiological Doses Maintains Bone Mineral Density and Mechanical Strength Despite Significant Weight Loss

Maximal Strength Training in Postmenopausal Women With Osteoporosis or Osteopenia

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone

Body composition in adults born preterm with very low birth weight

Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells

Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H+/K+ATPase Beta Subunit KO Mice

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas

Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice

Mo1082 The Effect of Three Months use of Proton Pump Inhibitors on Bone Mineral Density, Bone Markers and Calcium Metabolism in Men With Gastroesophageal Reflux Disease

Long-term serotonin effects in the rat are prevented by terguride

Enamel matrix derivative stimulates expression and secretion of resistin in mesenchymal cells

495 WITHDRAWN

Sa1332 GASTRIC CORPUS MUCOSAL HYPERPLASIA AND NEUROENDOCRINE CELL HYPERPASIA, BUT NOT SPASMOLYTIC POLYPEPTICE-EXPRESSING METAPLASIA, IS PREVENTED BY A GASTRIN-BLOCKER IN H+/K+ ATPASE BETA SUBUNIT DEFICIENT MICE

Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H super(+)/K super(+)ATPase Beta Subunit KO Mice

Heavy, Explosive Strength Training For Postmenopausal Women With Osteoporosis: A Pilot Study

Different skeletal effects of the peroxisome proliferator activated receptor [alpha] agonist fenofibrate and the PPAR[gamma] agonist pioglitazone

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)I- agonist fenofibrate and the PPARI3 agonist pioglitazone

Engineering of Inflammation-Resistant Osteochondral Cells

Alterations in the vitamin D endocrine system during pregnancy: A longitudinal study of 855 healthy Norwegian women

Maternal vitamin D status in pregnancy and molar incisor hypomineralisation and hypomineralised second primary molars in the offspring at 7–9 years of age: a longitudinal study

Suchergebnisse filtern